Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency

Clinical Endocrinology

Volumn 86, Issue 2, 2017, Pages 223-228

  Bachelot, Anne ^a,b   Nicolas, Carole ^a,b   Bidet, Maud ^c   Dulon, Jérôme ^a   Leban, Monique ^a   Golmard, Jean Louis ^a,b   Polak, Michel ^c,d   Touraine, Philippe ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; PRASTERONE;

ADULT; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY FUNCTION; PREGNANCY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; FERTILITY; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; HUMANS; OVARY; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY; PROGNOSIS; YOUNG ADULT;

EID: 84995377369     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.13105     Document Type: Article

References (23)

1. Beck-Peccoz, P. & Persani, L. (2006) Premature ovarian failure. Orphanet Journal of Rare Disease, 1, 9.
2. Nelson, L.M. (2009) Clinical practice. Primary ovarian insufficiency. New England Journal of Medicine, 360, 606–614.
3. Bachelot, A., Rouxel, A., Massin, N., et al. (2009) Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure. European Journal of Endocrinology, 161, 179–187.
4. Bidet, M., Bachelot, A., Bissauge, E., et al. (2011) Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 96, 3864–3872.
5. Rebar, R.W. & Connolly, H.V. (1990) Clinical features of young women with hypergonadotropic amenorrhea. Fertility and Sterility, 53, 804–810.
6. Nelson, L.M., Anasti, J.N., Kimzey, L.M., et al. (1994) Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 79, 1470–1475.
7. Conway, G.S., Kaltsas, G., Patel, A., et al. (1996) Characterization of idiopathic premature ovarian failure. Fertility and Sterility, 65, 337–341.
8. van Kasteren, Y.M. & Schoemaker, J. (1999) Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Human Reproduction Update, 5, 483–492.
9. Nelson, L.M., Kimzey, L.M., White, B.J., et al. (1992) Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Fertility and Sterility, 57, 50–55.
10. Taylor, A.E., Adams, J.M., Mulder, J.E., et al. (1996) A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. Journal of Clinical Endocrinology and Metabolism, 81, 3615–3621.
11. Kreiner, D., Droesch, K., Navot, D., et al. (1988) Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure. Obstetrics and Gynecology, 72, 926–928.
12. Bidet, M., Bachelot, A. & Touraine, P. (2008) Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents. Current Opinion in Obstetrics and Gynecology, 20, 416–420.
13. Wallace, W.H. & Kelsey, T.W. (2004) Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography. Human Reproduction, 19, 1612–1617.
14. van Kasteren, Y.M., Hoek, A. & Schoemaker, J. (1995) Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. Fertility and Sterility, 64, 273–278.
15. Surrey, E.S. & Cedars, M.I. (1989) The effect of gonadotropin suppression on the induction of ovulation in premature ovarian failure patients. Fertility and Sterility, 52, 36–41.
16. Tartagni, M., Cicinelli, E., De Pergola, G., et al. (2007) Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertility and Sterility, 87, 858–861.
17. Badawy, A., Goda, H. & Ragab, A. (2007) Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reproductive Biomedicine Online, 15, 215–219.
18. Sowers, M.R., Eyvazzadeh, A.D., McConnell, D., et al. (2008) Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. Journal of Clinical Endocrinology and Metabolism, 93, 3478–3483.
19. Benetti-Pinto, C.L., Bedone, A.J. & Magna, L.A. (2005) Evaluation of serum androgen levels in women with premature ovarian failure. Fertility and Sterility, 83, 508–510.
20. Bachelot, A., Meduri, G., Massin, N., et al. (2005) Ovarian steroidogenesis and serum androgen levels in patients with premature ovarian failure. Journal of Clinical Endocrinology and Metabolism, 90, 2391–2396.
21. Narkwichean, A., Jayaprakasan, K., Maalouf, W.E., et al. (2014) Effects of dehydroepiandrosterone on in vivo ovine follicular development. Human Reproduction, 29, 146–154.
22. Van Disseldorp, J., Faddy, M.J., Themmen, A.P., et al. (2008) Relationship of serum antimullerian hormone concentration to age at menopause. Journal of Clinical Endocrinology and Metabolism, 93, 2129–2134.
23. Lunding, S.A., Aksglaede, L., Anderson, R.A., et al. (2015) AMH as predictor of premature ovarian insufficiency: a longitudinal study of 120 turner syndrome patients. Journal of Clinical Endocrinology and Metabolism, 100, E1030–E1038.